MENU
+Compare
PLSE
Stock ticker: NASDAQ
AS OF
Oct 8, 04:02 PM (EDT)
Price
$19.82
Change
-$0.04 (-0.20%)
Capitalization
1.34B

PLSE Pulse Biosciences Forecast, Technical & Fundamental Analysis

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue... Show more

PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PLSE with price predictions
Oct 07, 2025

Momentum Indicator for PLSE turns positive, indicating new upward trend

PLSE saw its Momentum Indicator move above the 0 level on September 15, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PLSE just turned positive on September 16, 2025. Looking at past instances where PLSE's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

PLSE moved above its 50-day moving average on September 15, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PLSE crossed bullishly above the 50-day moving average on September 18, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PLSE advanced for three days, in of 252 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLSE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PLSE broke above its upper Bollinger Band on October 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PLSE entered a downward trend on September 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PLSE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.804) is normal, around the industry mean (10.960). P/E Ratio (0.000) is within average values for comparable stocks, (55.358). PLSE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.743). PLSE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.000) is also within normal values, averaging (14.464).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PLSE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PLSE is expected to report earnings to fall 12.90% to -27 cents per share on November 17

Pulse Biosciences PLSE Stock Earnings Reports
Q3'25
Est.
$-0.27
Q4'24
Missed
by $0.07
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.10
The last earnings report on March 27 showed earnings per share of -31 cents, missing the estimate of -23 cents. With 102.11K shares outstanding, the current market capitalization sits at 1.34B.
A.I. Advisor
published General Information

General Information

a development stage company, which manufactures surgical and medical instruments

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3957 Point Eden Way
Phone
+1 510 906-4600
Employees
56
Web
https://www.pulsebiosciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GDIIX23.20N/A
N/A
Genter Dividend Income
HNVRX43.58N/A
N/A
Harbor Small Cap Value Retirement
HSWFX22.25N/A
N/A
Hartford Schroders International Stk F
JARSX15.16N/A
N/A
Easterly Global Real Estate R6
TINFX27.48-0.13
-0.47%
Thornburg International Growth R5

PLSE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with CERS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
+2.16%
CERS - PLSE
38%
Loosely correlated
-0.62%
CLPT - PLSE
32%
Poorly correlated
-0.75%
ARAY - PLSE
32%
Poorly correlated
-8.19%
TMCI - PLSE
32%
Poorly correlated
-4.76%
QDEL - PLSE
32%
Poorly correlated
-6.40%
More

Groups containing PLSE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
+2.16%
Pharmaceuticals
category (386 stocks)
21%
Poorly correlated
+0.38%
Pharmaceuticals: Other
category (103 stocks)
19%
Poorly correlated
+0.50%